Author

I. Gurbuzaslan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:plant (other)· 2 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

D. Yuksel· 2 shared G. Hasanova· 2 shared G. Mammadova· 2 shared M. Ilgin· 2 shared T. Mammedov· 2 shared A. Ozkul· 1 shared B. Gulec· 1 shared D. Say· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

D. Yuksel

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

High level production and characterization of truncated human angiotensin converting enzyme 2 in Nicotiana benthamiana plant as a potential therapeutic target in COVID-19

T. Mammedov, I. Gurbuzaslan, M. Ilgin, D. Yuksel, G. Mammadova, A. Ozkul, G. Hasanova

This study produces and characterizes truncated human ACE2 in plants, showing it binds SARS-CoV-2 spike protein and has anti-viral activity, with deglycosylated form being more effective.

bioRxiv · May 17, 2021 · PreprintBioengineering

Engineering, production and characterization of Spike and Nucleocapsid structural proteins of SARS-CoV-2 in Nicotiana benthamiana as vaccine candidates against COVID-19

T. Mammedov, D. Yuksel, M. Ilgin, I. Gurbuzaslan, B. Gulec, G. Mammadova, D. Say, G. Hasanova

This study produces and characterizes SARS-CoV-2 Spike and Nucleocapsid proteins in plants, showing they elicit high antibody titers and are promising vaccine candidates.

bioRxiv · Dec 29, 2020 · PreprintBioengineering